MedTrace Logo

Oxymetazoline Versus Sodium Hypochlorite as Hemostatic Agents in MTA Pulpotomy of Primary Molars

NCT07675330 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-06-30

No results posted yet for this study

Summary

This study aims to evaluate clinical and radiographic success of oxymetazoline versus sodium hypochlorite as hemostatic agents in MTA pulpotomy of primary molars.

Conditions

  • Pulp Disease, Dental
  • Pulp Therapy in Primary Molars
  • Pulpitis - Reversible
  • Pulp Inflammation
  • Vital Pulp Therapies
  • Carious Exposure of Pulp
  • Primary Molar Tooth
  • Primary Molar Pulpotomy

Interventions

OTHER

Oxymetazoline 0.05% nasal solution

Using 1 drop (\~0.05 mL) of 0.05% OXY (Normifrin Nasal spray, MUP, Egypt, and generic equivalents) delivered through a micro- brush or a small cotton pellet over pulp stumps to achieve hemostasis.

OTHER

Sodium Hypochlorite Solution

Compression of a sterile cotton pellet soaked in 5% NaOCl over the pulpal stumps for 5 min

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07675330 on ClinicalTrials.gov